News Weight Loss Drug Semaglutide Boom Pushes India To Consider Defining Biological Medicines As peptide-based blockbusters such as semaglutide enter the Indian market, regulators are examining gaps in drug laws governing biological products. Post navigation Previous: From Test Flight To ‘Trial’ Run: Karnataka HC Pauses Unique Trespass Case Against DroneNext: NIA Raids Government Medical College Anantnag Linked To ‘White Collar’ Terror Module More Stories News Opinion | Nitish Kumar’s Exit Marks The End Of The Mandal Era In Bihar News Over 5,100 Women Deployed At 1,140 National Highway Toll Plazas; More To Join: NHAI News RTI Says Telangana Govt Funded Revanth Reddy’s Harvard Course, Congress Rejects Claim